Disease_category,Disease,Protein,Protein_definition,Method,Nb_SNP,OR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MCAM,Cell surface glycoprotein MUC18,Inverse variance weighted,13,1.28 [1.05-1.56],0.0125654513047892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,0.97 [0.89-1.06],0.500180087126183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,42,1.00 [0.92-1.08],0.911592286587538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFASC,Neurofascin,Inverse variance weighted,19,0.95 [0.86-1.06],0.394146102920625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,1.02 [0.80-1.31],0.842342394426336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,42,0.87 [0.78-0.97],0.0156156893620431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Inverse variance weighted,2,0.86 [0.52-1.42],0.551323516442593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,10,0.87 [0.71-1.06],0.174737270987592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C7,Complement component C7,Inverse variance weighted,60,1.00 [0.95-1.06],0.879432828342329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LPO,Lactoperoxidase,Inverse variance weighted,34,1.02 [0.94-1.11],0.572698220883074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASE6,Ribonuclease K6,Inverse variance weighted,20,1.07 [0.97-1.19],0.149788735601722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,19,0.80 [0.68-0.95],0.0114469694411798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHAD,Chondroadherin,Inverse variance weighted,15,1.00 [0.89-1.14],0.965397005419594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCN4,CCN family member 4,Inverse variance weighted,40,1.01 [0.93-1.10],0.808511026231294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCAN,Brevican core protein,Inverse variance weighted,15,0.94 [0.78-1.13],0.497700473092037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL17C,Interleukin-17C,Inverse variance weighted,8,0.76 [0.59-0.99],0.040861574660667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,1.06 [0.91-1.24],0.470522488878001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COLEC12,Collectin-12,Inverse variance weighted,13,1.18 [0.99-1.42],0.067449444728353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,1.11 [0.55-2.24],0.769211717923855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,13,0.74 [0.43-1.29],0.289728106393853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,8,1.03 [0.90-1.17],0.708099512764384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF5,Fibroblast growth factor 5,Inverse variance weighted,43,1.06 [0.99-1.14],0.112804855271803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,1.08 [0.82-1.42],0.598804530539369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PYY,Peptide YY,Inverse variance weighted,16,1.08 [0.94-1.24],0.270870330408317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFNA4,Ephrin-A4,Inverse variance weighted,5,0.94 [0.68-1.32],0.733591453241335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOA4,Apolipoprotein A-IV,Inverse variance weighted,5,0.82 [0.50-1.34],0.417790760264518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AFP,Alpha-fetoprotein,Inverse variance weighted,70,0.92 [0.84-1.02],0.133365401547968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEMA7A,Semaphorin-7A,Inverse variance weighted,25,1.12 [0.93-1.35],0.241722572281436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,18,0.94 [0.83-1.06],0.306932354762471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,0.84 [0.25-2.85],0.78058379803824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,1.07 [0.79-1.45],0.674481466299047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.10 [0.53-2.30],0.792009905885524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPOCK1,Testican-1,Inverse variance weighted,31,0.97 [0.82-1.16],0.771151482622433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,1.11 [0.61-2.00],0.731960052435664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,13,1.16 [0.95-1.41],0.145785994907026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LEPR,Leptin receptor,Inverse variance weighted,13,0.96 [0.80-1.16],0.663697671215122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,15,0.98 [0.80-1.20],0.822812475338744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,29,1.05 [0.96-1.14],0.270952893980189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,B2M,Beta-2-microglobulin,Inverse variance weighted,7,1.17 [0.79-1.73],0.436612295410492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRE5,Adhesion G protein-coupled receptor E5,Inverse variance weighted,16,1.14 [1.00-1.30],0.057839301691835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MDK,Midkine,Inverse variance weighted,19,1.18 [0.98-1.42],0.0732619130582314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CREG1,Protein CREG1,Inverse variance weighted,24,0.94 [0.86-1.03],0.192982150000751
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,15,1.13 [0.91-1.41],0.277617995515089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,5,0.96 [0.55-1.67],0.884973930199532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,17,1.01 [0.90-1.14],0.830875043296322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,18,0.80 [0.62-1.02],0.0744966823996282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,19,0.92 [0.81-1.04],0.192309111628595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GUCA2A,Guanylin,Inverse variance weighted,16,0.85 [0.69-1.04],0.113865843171164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,28,1.01 [0.93-1.09],0.876133028384904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,29,0.99 [0.89-1.10],0.787085917679637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK11,Kallikrein-11,Inverse variance weighted,19,1.14 [1.05-1.24],0.0026596856329268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,41,0.94 [0.83-1.07],0.354939715094355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,17,1.02 [0.90-1.16],0.732977809434199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK4,Kallikrein-4,Inverse variance weighted,20,1.03 [0.90-1.18],0.666726248603068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LCN15,Lipocalin-15,Inverse variance weighted,22,0.91 [0.83-1.00],0.0535314436936696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD59,CD59 glycoprotein,Inverse variance weighted,8,1.04 [0.84-1.28],0.735314209737729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCN2,Transcobalamin-2,Inverse variance weighted,66,1.03 [0.97-1.09],0.310621022210268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH17,Cadherin-17,Inverse variance weighted,44,1.00 [0.92-1.09],0.956280280194761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERBB4,Receptor tyrosine-protein kinase erbB-4,Inverse variance weighted,24,0.94 [0.83-1.08],0.381021830482973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HEPH,Hephaestin,Inverse variance weighted,6,1.14 [0.93-1.39],0.218152875587675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRSS8,Prostasin,Inverse variance weighted,19,1.20 [0.98-1.48],0.0750945243736963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AREG,Amphiregulin,Inverse variance weighted,7,1.15 [0.82-1.62],0.425324266258578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMPRSS15,Enteropeptidase,Inverse variance weighted,11,0.97 [0.65-1.45],0.88662183142862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,15,0.99 [0.88-1.12],0.904051515737827
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,50,0.96 [0.89-1.03],0.266502077871136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD164,Sialomucin core protein 24,Inverse variance weighted,11,1.03 [0.85-1.25],0.754551602901281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,15,1.06 [0.89-1.26],0.537249504505001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,17,0.95 [0.72-1.25],0.724748981018418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH1,Cadherin-1,Inverse variance weighted,17,0.92 [0.78-1.09],0.350124957876699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPA2,Carboxypeptidase A2,Inverse variance weighted,27,1.00 [0.89-1.12],0.956076612292534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NECTIN2,Nectin-2,Inverse variance weighted,8,0.85 [0.71-1.03],0.0900685486165046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,21,0.88 [0.69-1.12],0.31440058302627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSG1,Pregnancy-specific beta-1-glycoprotein 1,Inverse variance weighted,74,1.01 [0.97-1.05],0.754555058373706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DLL1,Delta-like protein 1,Inverse variance weighted,13,0.83 [0.66-1.06],0.131222456751851
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DMP1,Dentin matrix acidic phosphoprotein 1,Inverse variance weighted,17,0.77 [0.63-0.95],0.0145642407393547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM3C,Protein FAM3C,Inverse variance weighted,5,1.04 [0.69-1.56],0.841356528776014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,75,0.99 [0.92-1.05],0.675424937227571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1.00 [0.94-1.07],0.970261587048108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,42,0.96 [0.88-1.04],0.282481058227994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD302,CD302 antigen,Inverse variance weighted,17,0.88 [0.74-1.05],0.154983729684543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG1A,Lithostathine-1-alpha,Inverse variance weighted,26,1.03 [0.91-1.17],0.602161214120185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD27,CD27 antigen,Inverse variance weighted,18,1.05 [0.90-1.22],0.525454182098972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS4,Galectin-4,Inverse variance weighted,19,0.93 [0.83-1.05],0.257923038832023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CST3,Cystatin-C,Inverse variance weighted,13,1.24 [1.05-1.46],0.0118135704874637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPP6,Dipeptidyl aminopeptidase-like protein 6,Inverse variance weighted,14,0.98 [0.79-1.20],0.821595665146432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1.14 [0.92-1.40],0.235416070159763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,1.05 [0.58-1.89],0.868771874897999
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGRN,Agrin,Inverse variance weighted,31,0.95 [0.82-1.10],0.490441985994441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GCG,Pro-glucagon,Inverse variance weighted,2,1.11 [0.56-2.20],0.759786389677845
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,11,0.97 [0.68-1.37],0.852769130294328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,18,1.04 [0.83-1.29],0.7598241097505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,17,0.99 [0.84-1.16],0.902193639559587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,5,0.99 [0.47-2.06],0.971452824532691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,5,1.32 [0.87-2.01],0.188169004470362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFF2,Trefoil factor 2,Inverse variance weighted,16,0.95 [0.79-1.14],0.591694288930747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,35,1.05 [0.95-1.16],0.334781003288835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,10,0.98 [0.85-1.15],0.842625946952388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WNT9A,Protein Wnt-9a,Inverse variance weighted,7,1.03 [0.70-1.52],0.869371844419556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,31,1.13 [0.94-1.36],0.178922572573457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,16,1.05 [0.95-1.16],0.321816052003398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOTCH1,Neurogenic locus notch homolog protein 1,Inverse variance weighted,9,1.06 [0.94-1.19],0.329828766417196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,26,1.03 [0.92-1.14],0.640717616613222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP4,"Fatty acid-binding protein, adipocyte",Inverse variance weighted,2,0.53 [0.13-2.20],0.381949546380472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DKK4,Dickkopf-related protein 4,Inverse variance weighted,18,1.09 [0.87-1.36],0.442614152945658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP12,Macrophage metalloelastase,Inverse variance weighted,21,0.92 [0.85-0.99],0.036257856406055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA9,Carbonic anhydrase 9,Inverse variance weighted,11,1.11 [0.90-1.38],0.327994177132032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,19,1.05 [0.90-1.23],0.51745390867008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TACSTD2,Tumor-associated calcium signal transducer 2,Inverse variance weighted,36,0.93 [0.87-1.00],0.0515763315877835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,18,1.07 [0.91-1.25],0.423770323627127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRE2,Adhesion G protein-coupled receptor E2,Inverse variance weighted,19,1.05 [0.94-1.17],0.376911785049491
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAYN,Layilin,Inverse variance weighted,23,0.97 [0.86-1.09],0.620217649686056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,9,1.15 [0.84-1.55],0.382220728012658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCG2,Secretogranin-2,Inverse variance weighted,3,1.08 [0.67-1.74],0.756646654789079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPON1,Spondin-1,Inverse variance weighted,25,1.00 [0.87-1.14],0.942076181757749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,9,1.11 [0.86-1.43],0.42043964002797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM3D,Protein FAM3D,Inverse variance weighted,56,1.02 [0.95-1.10],0.590765330536973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",Inverse variance weighted,7,0.92 [0.78-1.08],0.31347600713704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCN,Decorin,Inverse variance weighted,3,0.81 [0.43-1.53],0.517405202020877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,34,1.02 [0.88-1.18],0.786875225224731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REN,Renin,Inverse variance weighted,12,1.06 [0.86-1.29],0.584326748246195
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFNA1,Ephrin-A1,Inverse variance weighted,15,1.05 [0.92-1.21],0.476922127751222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCAN,Neurocan core protein,Inverse variance weighted,23,0.96 [0.78-1.19],0.711974695477223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFF3,Trefoil factor 3,Inverse variance weighted,10,1.13 [0.84-1.54],0.420308034049445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RTN4R,Reticulon-4 receptor,Inverse variance weighted,26,1.05 [0.96-1.15],0.308875674238487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,17,0.89 [0.74-1.06],0.196836709092007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VEGFD,Vascular endothelial growth factor D,Inverse variance weighted,7,1.01 [0.78-1.33],0.918433907483581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,18,1.03 [0.90-1.17],0.707923631288081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRP1,Neuropilin-1,Inverse variance weighted,26,0.97 [0.85-1.10],0.587097260835257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NECTIN4,Nectin-4,Inverse variance weighted,12,1.13 [0.97-1.31],0.123029092295058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA12,Carbonic anhydrase 12,Inverse variance weighted,20,1.03 [0.91-1.16],0.67073185377587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,22,0.99 [0.86-1.14],0.903696046206103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMBP,Protein AMBP,Inverse variance weighted,5,1.09 [0.62-1.90],0.772814751997016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BOC,Brother of CDO,Inverse variance weighted,15,1.04 [0.87-1.24],0.676461267290269
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,4,0.96 [0.73-1.26],0.752055659536252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DSG2,Desmoglein-2,Inverse variance weighted,22,1.04 [0.85-1.27],0.709090465170493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PKD1,Polycystin-1,Inverse variance weighted,23,1.08 [0.95-1.22],0.257978605479355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,1.02 [0.71-1.44],0.932035966327704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,43,1.00 [0.94-1.06],0.923501849150996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASET2,Ribonuclease T2,Inverse variance weighted,25,0.99 [0.91-1.09],0.850598945188084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,5,0.91 [0.64-1.29],0.588334632101631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD160,CD160 antigen,Inverse variance weighted,36,0.97 [0.87-1.07],0.523495921647486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,14,1.06 [0.81-1.38],0.670608077806882
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC3B,Tetranectin,Inverse variance weighted,9,0.97 [0.79-1.17],0.72504256141813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLITRK6,SLIT and NTRK-like protein 6,Inverse variance weighted,29,1.01 [0.93-1.10],0.814933469620455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DSC2,Desmocollin-2,Inverse variance weighted,16,1.00 [0.85-1.17],0.957643515108973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,13,1.20 [0.98-1.48],0.0819267202794094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,11,0.86 [0.70-1.06],0.164054419697347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GDF15,Growth/differentiation factor 15,Inverse variance weighted,14,0.96 [0.76-1.22],0.741582725106166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM3B,Protein FAM3B,Inverse variance weighted,26,1.05 [0.97-1.14],0.258913602462164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL25,C-C motif chemokine 25,Inverse variance weighted,49,0.95 [0.89-1.01],0.102949718923395
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,13,1.03 [0.98-1.10],0.244691381821785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPNMB,Transmembrane glycoprotein NMB,Inverse variance weighted,22,0.99 [0.95-1.03],0.628049284164029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AOC3,Membrane primary amine oxidase,Inverse variance weighted,36,0.96 [0.88-1.03],0.24625291526613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,3,1.06 [0.62-1.81],0.827646335933036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,12,1.11 [0.94-1.31],0.237214220840026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,30,1.09 [0.97-1.23],0.138765622430328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,34,0.92 [0.85-1.00],0.0422610243703494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,0.89 [0.60-1.31],0.546915040300504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,20,1.00 [0.90-1.11],0.939231046260376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADA2,Adenosine deaminase 2,Inverse variance weighted,18,1.10 [0.93-1.29],0.263249475552178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD276,CD276 antigen,Inverse variance weighted,47,1.01 [0.94-1.09],0.799042914194881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP7,Matrilysin,Inverse variance weighted,15,1.10 [0.92-1.32],0.300913820456155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BGLAP,Osteocalcin,Inverse variance weighted,10,0.92 [0.65-1.30],0.634067541005048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,0.90 [0.72-1.12],0.329180091434079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB6,Integrin beta-6,Inverse variance weighted,24,1.12 [1.01-1.25],0.0402526585429378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,8,0.97 [0.76-1.25],0.830288289625904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,61,1.08 [1.02-1.14],0.0093314750734557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,0.98 [0.59-1.64],0.94606186439116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG1B,Lithostathine-1-beta,Inverse variance weighted,26,1.02 [0.91-1.15],0.685160734329294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,15,1.01 [0.86-1.17],0.936916229963425
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,40,0.97 [0.89-1.06],0.512199007620887
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MUC13,Mucin-13,Inverse variance weighted,13,0.85 [0.72-1.01],0.0628579425096717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLA2G10,Group 10 secretory phospholipase A2,Inverse variance weighted,26,1.09 [0.94-1.26],0.240487070777492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFF1,Trefoil factor 1,Inverse variance weighted,14,0.94 [0.82-1.08],0.367670217560839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OGN,Mimecan,Inverse variance weighted,37,1.03 [0.94-1.13],0.550634339822393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA5,Annexin A5,Inverse variance weighted,2,0.86 [0.38-1.96],0.717622580369382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,54,1.01 [0.93-1.09],0.852585772188994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,75,1.02 [0.97-1.07],0.504810552268014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,5,1.44 [0.74-2.81],0.286137635105668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,XG,Glycoprotein Xg,Inverse variance weighted,2,0.32 [0.15-0.67],0.0023561610174676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,POF1B,Protein POF1B,Inverse variance weighted,4,0.77 [0.52-1.14],0.199089725166976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRN,Progranulin,Inverse variance weighted,46,0.91 [0.85-0.99],0.0212840624005953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FSTL3,Follistatin-related protein 3,Inverse variance weighted,7,1.04 [0.69-1.58],0.854527664486577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.00 [0.86-1.16],0.959844165436534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,17,1.18 [0.99-1.39],0.0596607666010608
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,31,1.08 [0.97-1.21],0.151909771534365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,11,0.84 [0.60-1.16],0.277966743548394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,6,0.85 [0.71-1.01],0.0635332320681764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLXNB2,Plexin-B2,Inverse variance weighted,37,0.98 [0.94-1.03],0.538212596817739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL11,Eotaxin,Inverse variance weighted,11,1.11 [0.96-1.29],0.159183951244196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,4,1.07 [0.63-1.83],0.804730910028761
